Research project led by Bailey Hanna, MS, RDN - no affiliate links, ads or sponsored products.
A single placebo-controlled, double-blind crossover trial involving 23 participants with IBS examined the effects of Lactobacillus brevis KB290.1 The study faced several limitations, including a high attrition rate, with over 34% of participants dropping out during the study period.
Results:
Key Takeaway: The evidence supporting Lactobacillus brevis KB290 is derived from a single crossover trial of suboptimal quality conducted in individuals with IBS. This trial does not indicate the superiority of this probiotic over placebo.
Recommended Dose: None at this time. Further research is needed.
Reference:
There is insufficient evidence demonstrating benefits for IBS with this probiotic. Therefore, we do not provide guidance on finding a commercial product containing this strain/blend.
This probiotic has low to moderate quality studies in IBS populations supporting it. View our evidence evaluation framework to learn how we assess the quality of studies.
Add condition
The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial
Biopsychosoc Med 2012; 6: 16
PEOPLE >=6 years
During the placebo consumption period, there was no significant difference compared to the washout period. However, during the test capsule consumption period, there was a notable decrease in the frequencies of watery and mushy feces compared to the pre-consumption observation period.
Despite these observations, our independent analysis found no statistically significant changes.
No data
When examining bowel movement patterns, researchers looked at several factors, including the frequency of bowel movements, the volume and color of feces, the physical sensations experienced post-bowel movement, and the duration of the bowel movements.
Their findings revealed no significant differences across these variables during the different periods studied.
Although no statistically significant difference was observed in any quality of life (QOL) items (including physical, emotional, social activities, pain, and overall health) among the study periods, it is worth noting that the mean score for all items decreased during the test capsule consumption period.